NR2E3

Advertisement

cGxPJobs Banner

Ocugen Gains Provisional Approval for OCU400 in The Bahamas

MALVERN, Pa. — September 25, 2026 Ocugen Inc. announced that its investigational modifier gene therapy OCU400 has received provisional...

By cGxPwire Editor
September 26, 2026

Read More

Advertisement

cGxPJobs

Directory